A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma
Rebecca L. Johnston(QIMR Berghofer Medical Research Institute), Christian Steidl(University of British Columbia), David W. Scott(BC Cancer Agency), Cindy L. Schwartz(Brown University), Debra L. Friedman(Vanderbilt University), Randy D. Gascoyne(BC Cancer Agency), Lydia Visser(University Medical Center Groningen), Adèle Telenius(BC Cancer Agency), Terzah M. Horton(Unknown), Arjan Diepstra, Anja Mottok(Comprehensive Cancer Center Mainfranken), Fong Chun Chan(BC Cancer Agency), Kara M. Kelly(Roswell Park Comprehensive Cancer Center), Aixiang Jiang(Simon Fraser University)
Cited by 17
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k